FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007654410> ?p ?o ?g. }

• W3007654410 endingPage "800" @default.
• W3007654410 startingPage "784" @default.
• W3007654410 abstract "Triple-negative breast cancer (TNBC) shows limited therapeutic efficacy. PARP inhibitor has been approved to treat advanced BRCA-mutant breast cancer but shows high resistance. Therefore, the development of new therapeutics that sensitize TNBC irrespective of BRCA status is urgently needed. The neddylation pathway plays a critical role in many physiological processes by regulating the degradation of proteins. MLN4924, a selective inhibitor of the key neddylation enzyme NEDD8 Activation Enzyme (NAE1), shows higher sensitivity to both BRCA1-wild type and -mutant TNBCs compared to other breast cancer subtypes. MLN4924 induced re-replication with >4N DNA content leading to robust DNA damage. Accumulation of unrepaired DNA damage resulted in S and G2/M arrest causing apoptosis and senescence, due to the stabilization of the replication initiation protein CDT1 and the accumulation of cell cycle proteins upon MLN4924 treatment. Moreover, adding MLN4924 to the standard TNBC chemotherapeutic agent cisplatin increased the DNA damage level, further enhancing the sensitivity. In vivo, MLN4924 reduced tumor growth in a NOD-SCID mouse xenograft model by inducing DNA damage which was further augmented with the MLN4924 and cisplatin cotreatment. NAE1 is overexpressed in TNBC cell lines and in patients compared to other breast cancer subtypes suggesting that NAE1 status is prognostic of MLN4924 treatment response and outcome. Taken together, we demonstrated the mechanism of TNBC sensitization by the MLN4924 and MLN4924/cisplatin treatments irrespective of BRCA1 status, provided a strong justification for using MLN4924 alone or in combination with cisplatin, and identified a genetic background in which this combination will be particularly effective." @default.
• W3007654410 created "2020-03-06" @default.
• W3007654410 creator A5024388674 @default.
• W3007654410 creator A5053269103 @default.
• W3007654410 creator A5054228072 @default.
• W3007654410 creator A5064981120 @default.
• W3007654410 creator A5072440595 @default.
• W3007654410 date "2020-02-25" @default.
• W3007654410 modified "2023-10-12" @default.
• W3007654410 title "Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment" @default.
• W3007654410 cites W1509901905 @default.
• W3007654410 cites W168811426 @default.
• W3007654410 cites W1928092242 @default.
• W3007654410 cites W1937647259 @default.
• W3007654410 cites W1965186484 @default.
• W3007654410 cites W1968048579 @default.
• W3007654410 cites W1969663349 @default.
• W3007654410 cites W1988031203 @default.
• W3007654410 cites W1993043513 @default.
• W3007654410 cites W1996516839 @default.
• W3007654410 cites W1996571302 @default.
• W3007654410 cites W2037955447 @default.
• W3007654410 cites W2039478924 @default.
• W3007654410 cites W2042499074 @default.
• W3007654410 cites W2049986951 @default.
• W3007654410 cites W2051887481 @default.
• W3007654410 cites W2054940324 @default.
• W3007654410 cites W2068724764 @default.
• W3007654410 cites W2068868056 @default.
• W3007654410 cites W2074446011 @default.
• W3007654410 cites W2076194625 @default.
• W3007654410 cites W2076798160 @default.
• W3007654410 cites W2085006244 @default.
• W3007654410 cites W2096027508 @default.
• W3007654410 cites W2096439168 @default.
• W3007654410 cites W2105560882 @default.
• W3007654410 cites W2107747328 @default.
• W3007654410 cites W2109148470 @default.
• W3007654410 cites W2117639046 @default.
• W3007654410 cites W2120380960 @default.
• W3007654410 cites W2138533207 @default.
• W3007654410 cites W2140219059 @default.
• W3007654410 cites W2140252926 @default.
• W3007654410 cites W2142460765 @default.
• W3007654410 cites W2142486051 @default.
• W3007654410 cites W2159682317 @default.
• W3007654410 cites W2163280499 @default.
• W3007654410 cites W2171972386 @default.
• W3007654410 cites W2184335538 @default.
• W3007654410 cites W2327334027 @default.
• W3007654410 cites W2403580382 @default.
• W3007654410 cites W2801432543 @default.
• W3007654410 cites W754635985 @default.
• W3007654410 doi "https://doi.org/10.18632/oncotarget.27485" @default.
• W3007654410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7055543" @default.
• W3007654410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32166000" @default.
• W3007654410 hasPublicationYear "2020" @default.
• W3007654410 type Work @default.
• W3007654410 sameAs 3007654410 @default.
• W3007654410 citedByCount "5" @default.
• W3007654410 countsByYear W30076544102021 @default.
• W3007654410 countsByYear W30076544102022 @default.
• W3007654410 countsByYear W30076544102023 @default.
• W3007654410 crossrefType "journal-article" @default.
• W3007654410 hasAuthorship W3007654410A5024388674 @default.
• W3007654410 hasAuthorship W3007654410A5053269103 @default.
• W3007654410 hasAuthorship W3007654410A5054228072 @default.
• W3007654410 hasAuthorship W3007654410A5064981120 @default.
• W3007654410 hasAuthorship W3007654410A5072440595 @default.
• W3007654410 hasBestOaLocation W30076544101 @default.
• W3007654410 hasConcept C104317684 @default.
• W3007654410 hasConcept C121608353 @default.
• W3007654410 hasConcept C126322002 @default.
• W3007654410 hasConcept C134459356 @default.
• W3007654410 hasConcept C143065580 @default.
• W3007654410 hasConcept C143425029 @default.
• W3007654410 hasConcept C182979987 @default.
• W3007654410 hasConcept C190283241 @default.
• W3007654410 hasConcept C25602115 @default.
• W3007654410 hasConcept C2776694085 @default.
• W3007654410 hasConcept C2778239845 @default.
• W3007654410 hasConcept C2779138821 @default.
• W3007654410 hasConcept C2780110267 @default.
• W3007654410 hasConcept C29537977 @default.
• W3007654410 hasConcept C45005369 @default.
• W3007654410 hasConcept C502942594 @default.
• W3007654410 hasConcept C530470458 @default.
• W3007654410 hasConcept C552990157 @default.
• W3007654410 hasConcept C55493867 @default.
• W3007654410 hasConcept C71924100 @default.
• W3007654410 hasConcept C82381507 @default.
• W3007654410 hasConcept C86803240 @default.
• W3007654410 hasConceptScore W3007654410C104317684 @default.
• W3007654410 hasConceptScore W3007654410C121608353 @default.
• W3007654410 hasConceptScore W3007654410C126322002 @default.
• W3007654410 hasConceptScore W3007654410C134459356 @default.
• W3007654410 hasConceptScore W3007654410C143065580 @default.
• W3007654410 hasConceptScore W3007654410C143425029 @default.

• next